- Update 24 August 2020
Evidence lags behind excitement over blood plasma as a coronavirus treatment
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 584, 505 (2020)
Updates & Corrections
Update 24 August 2020: The US Food and Drug Administration issued an emergency-use authorization on 23 August to treat COVID-19 with convalescent plasma.
Joyner, M. J. et al. J. Clin. Invest. https://doi.org/10.1172/JCI140200 (2020).
Joyner, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.08.12.20169359 (2020).
Joyner, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.07.29.20162917 (2020).
Landray, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.07.15.20151852 (2020).